Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $46.9400 (-1.84%) ($46.8200 - $46.9400) on Tue. Apr. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 51 | Latest Price | $46.9400(-1.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.79% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-17%) UNG(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $47.34 | 5 Day Moving Average | $47.46(-1.1%) | 10 Day Moving Average | $46.7(0.51%) | 20 Day Moving Average | $47.34(-0.84%) | To recent high | -13.3% | To recent low | 12.6% | Market Cap | $5.945b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |